Prevenar 13((R)) New Pneumococcal Vaccine for Small Children and Infants

被引：0
|
作者：
Kearns, Anette [1 ]
机构：
[1] Wyeth Lederle Pharma GmbH, Storchengasse 1, A-1150 Vienna, Austria
来源：
PADIATRIE UND PADOLOGIE | 2010年 / 45卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children
    Esposito, Susanna
    Principi, Nicola
    FUTURE MICROBIOLOGY, 2015, 10 (10) : 1599 - 1607
  • [22] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children
    Levy, Corinne
    Varon, Emmanuelle
    Bechet, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (01) : 131 - +
  • [23] Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era
    Yildirim, Inci
    Pelton, Stephen I.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 91 - 92
  • [24] Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
    Satzke, Catherine
    Dunne, Eileen M.
    Choummanivong, Molina
    Ortika, Belinda D.
    Neal, Eleanor F. G.
    Pell, Casey L.
    Nation, Monica L.
    Fox, Kimberley K.
    Nguyen, Cattram D.
    Gould, Katherine A.
    Hinds, Jason
    Chanthongthip, Anisone
    Xeuatvongsa, Anonh
    Mulholland, E. Kim
    Sychareun, Vanphanom
    Russell, Fiona M.
    VACCINE, 2019, 37 (02) : 296 - 305
  • [25] Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review
    Feemster, Kristen
    Weaver, Jessica
    Buchwald, Ulrike
    Banniettis, Natalie
    Cox, Kara S.
    Mcintosh, E. David
    Spoulou, Vana
    VACCINES, 2023, 11 (12)
  • [26] Heptavalent-pneumococcal conjugate vaccine (Prevenar™).: Differences in effectiveness between populations
    Guevara, M.
    Barricarte, A.
    Perez, B.
    Arriazu, M.
    Cenoz, M. Garcia
    Castilla, J.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2008, 31 (02) : 171 - 192
  • [27] Evaluation of pneumococcal conjugate vaccine (Prevenar) in patients with myeloma and chronic lymphocytic leukaemia
    Greenfield, H. M.
    Borrow, R.
    Warrington, R.
    Balmer, P.
    Cavet, J.
    Adams, J.
    Mutton, K.
    Yin, J. A. Liu
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 6 - 6
  • [28] Your guide to the new pneumococcal vaccine for children
    Campos-Outcalt, Doug
    JOURNAL OF FAMILY PRACTICE, 2010, 59 (07): : 394 - 398
  • [29] Immunogenicity of the 13-valent pneumococcal conjugate vaccine (Prevenar 13) in patients with primary systemic vasculitis receiving standard of care therapy and controls
    Kapetanovic, M. C.
    Nived, P.
    Nagel, J.
    Geborek, P.
    Jonsson, G.
    Skattum, L.
    Saxne, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 46 - 47
  • [30] Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
    Sucher, Allana J.
    Chahine, Elias B.
    Nelson, Michael
    Sucher, Brandon J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1516 - 1524
12345